Live
FierceBiotechBial bails after Parkinson’s fail, axing asset over phase 2 missClinical OMICsGenome Wide Analysis Broadens Genetic Knowledge of AnxietyFierceBiotechGSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancerLabiotechPharma in Spain: why global investors and innovators are moving inEndpoints NewsGSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6BeLifeExperience shapes the transformation of olfactory representations along the cortico-hippocampal pathway10x Genomics Blog10x Genomics (NASDAQ: TXG) grants 8,829 RSUs to director Suliman - Stock Titan10x Genomics Blog10x Genomics (TXG) awards 8,829 RSUs to board director - Stock Titan10x Genomics News10x Genomics (TXG) awards director Kimberly Popovits 8,829 RSUs - Stock Titan10x Genomics News10x Genomics (TXG) director receives 8,829 RSU grant, lifts holdings - Stock Titan10x Genomics News10x Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com10x Genomics Blog10x Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com
BioWorld 4. Dez. 2025

Guidance on primate testing is ‘genuine’ animal welfare progress

Guidance on primate testing is ‘genuine’ animal welfare progress

Original
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.